Tenofovir in treatment of Iranian patients with chronic hepatitis B virus infection: An open‑label case series
Tenofovir in treatment of Iranian patients with chronic hepatitis B virus infection: An open‑label case series

. Behrooz Ataei; . Mahsa Khodadoostan; . Babk Pouria; . Peyman Adibi

Volume 5, Issue 3 , July 2016, , Pages 166-170

Abstract
  Objective: Tenofovir is among the first‑line treatments for chronic hepatitis B (CHB) virus infection. We evaluated the efficacy and safety of Tenofovir in treatment of Iranian patients ...  Read More
Adherence to stress‑related mucosal damage prophylaxis guideline in patients admitted to the Intensive Care Unit
Adherence to stress‑related mucosal damage prophylaxis guideline in patients admitted to the Intensive Care Unit

. Niloofar Rafinazari; . Saeed Abbasi; . Shadi Farsaei; . Marjan Mansourian; . Peyman Adibi

Volume 5, Issue 3 , July 2016, , Pages 186-192

Abstract
  Objective: Concern about adverse effects of the inconsistent use of stress‑related mucosal damage prophylaxis in intensive care unit (ICU) is increasing. Hence, this study ...  Read More
Evaluating the efficacy of Salsalate on prediabetic and diabetic patients with fatty liver: A randomized clinical trial
Evaluating the efficacy of Salsalate on prediabetic and diabetic patients with fatty liver: A randomized clinical trial

. Elham Faghihimani; . Masoud Amini; . Atoosa Adibi; . Zohreh Naderi; . Ali Toghiani; . Peyman Adibi

Volume 2, Issue 1 , January 2013, , Pages 40-43

Abstract
  Objective: Nearly two-third of the patients with type 2 diabetes have degrees of fatty liver; this may induce some side effects in them. This study aimed to find effect of salsalate ...  Read More